Shine-On BioMedical Co.,Ltd. (6926.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$64.00 (+0.00%) as of
Key statistics
- Market cap
- 3.19B
- EPS (TTM)
- -3.64
- Dividend yield
- 0.00%
- 52-week range
- 59.90 – 73.70
- Beta
- -0.14
- Revenue (TTM)
- 50.62M
- Profit margin
- 0.00%
- Volume
- 75.31k
About Shine-On BioMedical Co.,Ltd.
Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. Shine-On BioMedical Co.,Ltd. was founded in 2011 and is based in Taichung, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Taichung, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.